SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Galenica AG (GALNF) trades at a trailing P/E of 31.7, forward P/E of 29.5. Trailing earnings yield is 3.16%, forward earnings yield 3.39%. PEG 3.93.
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Forward P/E 29.5 (down from trailing 31.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 3.93 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 3.16% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 3.39% as earnings recover.
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GALNF
Valuation Multiples
P/E (TTM)31.7
Forward P/E29.5
PEG Ratio3.93
Forward PEG3.93
P/B Ratio0.00
P/S Ratio1.39
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.63
Forward EPS (Est.)$3.90
Book Value / Share$0.00
Revenue / Share$82.94
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.16%
Forward Earnings Yield3.39%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.67 |
$3.01B |
$83.39M |
2.8% |
| 2017 |
$2.42 |
$3.15B |
$118.8M |
3.8% |
| 2018 |
$3.00 |
$3.17B |
$147.55M |
4.7% |
| 2019 |
$2.53 |
$3.31B |
$124.99M |
3.8% |
| 2020 |
$3.48 |
$3.48B |
$172.25M |
4.9% |
| 2021 |
$3.38 |
$3.83B |
$167.68M |
4.4% |
| 2022 |
$3.32 |
$4.01B |
$165.13M |
4.1% |
| 2023 |
$5.72 |
$3.75B |
$173.6M |
4.6% |
| 2024 |
$3.67 |
$3.92B |
$182.95M |
4.7% |
| 2025 |
$3.63 |
$4.14B |
$181.19M |
4.4% |
